REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/07/2026
Back to search
Official data from USPTO
SK BIOTEK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/08/2026
Trademark type
Combined
Nice classes
5
Filing date
09/30/2015
Registration date
03/07/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2023
Last transaction
03/08/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
03
Owner location
SEOUL, KR
Examiner
SOBRAL, CHRISTINA
Law office
L90
Current location
TMEG LAW OFFICE 109
Mark description
The mark consists of the letters "SK" in red stylized font and the letters "biotek" in orange stylized font; to the top right of the "SK" portion of the mark is a design of wings; the inner portion of the wings is red, and the outer portion of the wings is orange; white is not claimed as a feature of the mark and only represents background or transparent areas.
Holders and representatives
Holders
SK INC.
SK HOLDINGS CO., LTD.
Representatives
Charles R Halloran KPPB LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical and veterinary preparations for treatment of central nervous system diseasescancer and metabolic diseases; sanitary preparations for medical use; biological preparations for medical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; biochemical preparations for medical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for pharmaceutical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases ; medical preparation of trace elements for human and animal usefor the treatment of central nervous system diseasescancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; blood solvent; chemical preparations for medicinal purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for medical or veterinary purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseasescancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseasescancer and metabolic diseases; bacteriological preparations for medical and veterinary use
Publications
History of USPTO decisions and trademark events.
33 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/26/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/26/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/26/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/16/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/16/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/16/2023
E815
TEAS SECTION 8 & 15 RECEIVED
02/17/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/07/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/07/2018
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
11/03/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/03/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
04/28/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2017
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
01/31/2017
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/28/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/19/2016
PUBO
PUBLISHED FOR OPPOSITION
07/19/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/29/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/13/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/07/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/07/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/07/2016
ALIE
ASSIGNED TO LIE
06/02/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/19/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/13/2016
GNRT
NON-FINAL ACTION E-MAILED
01/13/2016
CNRT
NON-FINAL ACTION WRITTEN
01/13/2016
DOCK
ASSIGNED TO EXAMINER
01/13/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/07/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/06/2015
NWAP
NEW APPLICATION ENTERED
10/03/2015
Continuous trademark protection
Get notified about every new filing that threatens SK BIOTEK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.